American Journal of Physiology: Renal, Fluid & Electrolyte Physiology (Abstracts) 2013-06-01

GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy.

Mengjie Li, Xufang Wang, Jiye Aa, Weisong Qin, Weibin Zha, Yongchun Ge, Linsheng Liu, Tian Zheng, Bei Cao, Jian Shi, Chunyan Zhao, Xinwen Wang, Xiaoyi Yu, Guangji Wang, Zhihong Liu

Index: Am. J. Physiol. Renal Physiol. 304(11) , F1317-24, (2013)

Full Text: HTML

Abstract

Early diagnosis of diabetic nephropathy (DN) is difficult although it is of crucial importance to prevent its development. To probe potential markers and the underlying mechanism of DN, an animal model of DN, the db/db mice, was used and serum and urine metabolites were profiled using gas chromatography/time-of-flight mass spectrometry. Metabolic patterns were evaluated based on serum and urine data. Principal component analysis of the data revealed an obvious metabonomic difference between db/db mice and controls, and db/db mice showed distinctly different metabolic patterns during the progression from diabetes to early, medium, and later DN. The identified metabolites discriminating between db/db mice and controls suggested that db/db mice have perturbations in the tricarboxylic acid cycle (TCA, citrate, malate, succinate, and aconitate), lipid metabolism, glycolysis, and amino acid turnover. The db/db mice were characterized by acidic urine, high TCA intermediates in serum at week 6 and a sharp decline thereafter, and gradual elevation of free fatty acids in the serum. The sharp drop of serum TCA intermediates from week 6 to 8 indicated the downregulated glycolysis and insulin resistance. However, urinary TCA intermediates did not decrease in parallel with those in the serum from week 6 to 10, and an increased portion of TCA intermediates in the serum was excreted into the urine at 8, 10, and 12 wk than at 6 wk, indicating kidney dysfunction occurred. The relative abundances of TCA intermediates in urine relative to those in serum were suggested as an index of renal damage.

Related Compounds

Structure Name/CAS No. Articles
3-hydroxybutyric acid Structure 3-hydroxybutyric acid
CAS:300-85-6
Arachidonic acid Structure Arachidonic acid
CAS:506-32-1
Citric Acid Structure Citric Acid
CAS:77-92-9
Succinic acid Structure Succinic acid
CAS:110-15-6
D-(+)-Malic acid Structure D-(+)-Malic acid
CAS:636-61-3
L-()-Malic acid disodium salt Structure L-()-Malic acid disodium salt
CAS:138-09-0
(±)-Malic Acid Structure (±)-Malic Acid
CAS:6915-15-7
Sodium DL-Malate Structure Sodium DL-Malate
CAS:676-46-0
allantoin Structure allantoin
CAS:97-59-6
Sodium (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate Structure Sodium (5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoate
CAS:6610-25-9